Barbara J McClure

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Cell death & disease

British journal of haematology

Blood

Leukemia & lymphoma

South Australian Health and Medical Research Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

South Australian Health and Medical Research Institute

Australia

Post Doctoral Researcher :: Precision Medicine Theme, Cancer Program

South Australian Health and Medical Research Institute (SAHMRI)

Australia

Research Assistant :: Cancer Theme

Centre for Cancer Biology, SA Pathology

Australia

Research Assistant :: Human Immunology

Instiute of Medical and Veterinary Science

Australia

Research Assistant :: Department of Haematology

Publications

Laura N Eadie, Elias Lagonik, Elyse C Page, Caitlin E Schutz, Susan L Heatley, Barbara J McClure, Michelle O Forgione, David T O Yeung, Timothy P Hughes, Deborah L White
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Blood 144 (9) (2024)
Laura N Eadie, Elias Lagonik, Elyse C Page, Caitlin E Schutz, Susan L Heatley, Barbara J McClure, Michelle O Forgione, David T O Yeung, Timothy P Hughes, Deborah L White
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Blood 144 (9) (2024)
Winnie L Kan, Barbara J McClure, Christopher N Hahn, Jason A Powell
The 10 th Barossa meeting: Cell Signalling to Cancer Medicine. Cell death & disease 15 (3) (2024)
Laura N Eadie, Elias Lagonik, Elyse C Page, Caitlin E Schutz, Susan L Heatley, Barbara J McClure, Michelle Olivia Forgione, David T O Yeung, Timothy P Hughes, Deborah L White
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Blood (2024)
Winnie L Kan, Barbara J McClure, Christopher N Hahn, Jason A Powell
The 10 th Barossa meeting: Cell Signalling to Cancer Medicine. Cell death & disease 15 (3) (2024)
Winnie L Kan, Barbara J McClure, Christopher N Hahn, Jason A Powell
The 10 th Barossa meeting: Cell Signalling to Cancer Medicine. Cell death & disease 15 (3) (2024)
Ashlee J Thomson, Jacqueline A Rehn, Susan L Heatley, Laura N Eadie, Elyse C Page, Caitlin Schutz, Barbara J McClure, Rosemary Sutton, Luciano Dalla-Pozza, Andrew S Moore, Matthew Greenwood, Rishi Sury Kotecha, Chun Yew Fong, Agnes S M Yong, David T Yeung, James Breen, Deborah L White
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients. Cancers 15 (19) (2023)
Elyse C Page, Susan L Heatley, Laura N Eadie, Barbara J McClure, Charles E de Bock, Sofia A Omari, David T Yeung, Timothy P Hughes, Paul Q Thomas, Deborah L White
HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. Oncogene (2021)
Charlotte E J Downes, Jacqueline Rehn, Susan L Heatley, David Yeung, Barbara J McClure, Deborah L White
Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia. British journal of haematology (2021)
Charlotte E J Downes, Barbara J McClure, John B Bruning, Elyse C Page, James Breen, Jacqueline A Rehn, David T Yeung, Deborah L White
Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia. NPJ precision oncology 5 (1) (2021)
Susan L Heatley, Kartini Asari, Caitlin E Schutz, Tamara M Leclercq, Barbara J McClure, Laura N Eadie, Timothy P Hughes, David T Yeung, Deborah L White
In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy. Leukemia & lymphoma 62 (5) (2021)
Barbara J McClure, Manika Pal, Susan L Heatley, Jacqueline Rehn, Caitlin Schutz, James Breen, Nicola C Venn, Rosemary Sutton, Seong Lin Khaw, David T Yeung, Deborah L White
Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features. British journal of haematology 196 (6) (2021)
Barbara J McClure, Susan L Heatley, Jacqueline Rehn, James Breen, Rosemary Sutton, Timothy P Hughes, Ram Suppiah, Tamas Revesz, Michael Osborn, Daniel White, David T Yeung, Deborah L White
High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse. British journal of haematology 191 (2) (2020)
Michelle Olivia Forgione, Barbara J McClure, David T O Yeung, Laura N Eadie, Deborah L White
MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategies. Genes, chromosomes & cancer (2020)

Barbara J McClure.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Barbara J McClure